SOLTAMOX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Soltamox, and when can generic versions of Soltamox launch?
Soltamox is a drug marketed by Mayne Pharma Commrcl and is included in one NDA.
The generic ingredient in SOLTAMOX is tamoxifen citrate. There are sixteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Soltamox
A generic version of SOLTAMOX was approved as tamoxifen citrate by ACTAVIS LABS FL INC on February 20th, 2003.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for SOLTAMOX?
- What are the global sales for SOLTAMOX?
- What is Average Wholesale Price for SOLTAMOX?
Summary for SOLTAMOX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Clinical Trials: | 21 |
Drug Prices: | Drug price information for SOLTAMOX |
What excipients (inactive ingredients) are in SOLTAMOX? | SOLTAMOX excipients list |
DailyMed Link: | SOLTAMOX at DailyMed |
Recent Clinical Trials for SOLTAMOX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Jose Pablo Leone | Phase 2 |
Translational Breast Cancer Research Consortium (TBCRC) | Phase 2 |
Eli Lilly and Company | Phase 2 |
Pharmacology for SOLTAMOX
Drug Class | Estrogen Agonist/Antagonist |
Mechanism of Action | Selective Estrogen Receptor Modulators |
US Patents and Regulatory Information for SOLTAMOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mayne Pharma Commrcl | SOLTAMOX | tamoxifen citrate | SOLUTION;ORAL | 021807-001 | Oct 29, 2005 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for SOLTAMOX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Mayne Pharma Commrcl | SOLTAMOX | tamoxifen citrate | SOLUTION;ORAL | 021807-001 | Oct 29, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for SOLTAMOX
See the table below for patents covering SOLTAMOX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 0893121 | ⤷ Sign Up | |
Portugal | 893121 | ⤷ Sign Up | |
Germany | 69804169 | ⤷ Sign Up | |
Austria | 214269 | ⤷ Sign Up | |
Spain | 2174388 | ⤷ Sign Up | |
Japan | H1171269 | ORAL LIQUID PHARMACEUTICAL PREPARATION | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |